Cadila Healthcare Limited
Indian Pharmaceutical Exporter · Cardiovascular Specialist · $34.9M Total Trade · DGFT Verified
Cadila Healthcare Limited is an Indian pharmaceutical exporter with a total trade value of $34.9M across 41 products in 17 therapeutic categories. Based on 814 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Carvedilol ($4.9M), Losartan ($3.6M), Spironolactone ($3.0M).
Cadila Healthcare Limited — Export Portfolio & Destination Treemap

Who is Cadila Healthcare Limited? — Company Overview & Market Position
Cadila Healthcare Limited, now known as Zydus Lifesciences Limited, is a leading Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat. Established in 1952 by the late Mr. Ramanbhai B. Patel, the company has evolved into a fully integrated global healthcare provider. In 1995, the group restructured, forming Cadila Healthcare under the Zydus group, marking a significant milestone in its growth trajectory.
The company operates across the entire pharmaceutical value chain, encompassing research, development, production, marketing, and distribution of pharmaceutical products. Its diverse portfolio includes formulations, active pharmaceutical ingredients (APIs), animal healthcare products, and wellness products. Zydus Lifesciences Limited is publicly listed on the National Stock Exchange of India under the ticker symbol CADILAHC.